China National Accord Medicines Corp Ltd (200028) — Capital Reinvestment Ratio
China National Accord Medicines Corp Ltd (200028) has a Capital Reinvestment Ratio of 0.03x as of June 2025, meaning it reinvests 0% of its operating cash flow (HK$1.83 Billion) in capital expenditures (HK$50.09 Million). See how much free cash does China National Accord Medicines Corp Ltd generate to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
China National Accord Medicines Corp Ltd Capital Reinvestment Ratio (1998–2025)
This chart tracks China National Accord Medicines Corp Ltd's Capital Reinvestment Ratio across 27 annual periods.
Annual Capital Reinvestment Ratio for China National Accord Medicines Corp Ltd (1998–2025)
Year-by-year Capital Reinvestment Ratio for China National Accord Medicines Corp Ltd from 1998 to 2025. For live market cap and broader valuation context, see market cap of China National Accord Medicines Corp Ltd.
| Year | Reinvestment Ratio | Operating CF (HKD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.13x | HK$1.64 Billion | HK$217.35 Million | ▲ +53.5% |
| 2024 | 0.09x | HK$3.27 Billion | HK$282.70 Million | ▼ -21.2% |
| 2023 | 0.11x | HK$2.94 Billion | HK$322.21 Million | ▼ -12.8% |
| 2022 | 0.13x | HK$2.56 Billion | HK$322.19 Million | ▼ -43.8% |
| 2021 | 0.22x | HK$1.66 Billion | HK$370.43 Million | ▲ +14.5% |
| 2020 | 0.20x | HK$1.50 Billion | HK$293.83 Million | ▲ +59.5% |
| 2019 | 0.12x | HK$2.00 Billion | HK$245.17 Million | ▼ -36.6% |
| 2018 | 0.19x | HK$1.32 Billion | HK$255.48 Million | ▲ +21.5% |
| 2017 | 0.16x | HK$1.29 Billion | HK$204.35 Million | ▼ -11.9% |
| 2016 | 0.18x | HK$1.47 Billion | HK$265.89 Million | ▼ -0.6% |
| 2015 | 0.18x | HK$1.05 Billion | HK$190.36 Million | ▼ -43.9% |
| 2013 | 0.32x | HK$465.03 Million | HK$150.50 Million | ▼ -45.8% |
| 2012 | 0.60x | HK$323.96 Million | HK$193.57 Million | ▼ -31.7% |
| 2011 | 0.88x | HK$227.32 Million | HK$198.97 Million | ▲ +110.6% |
| 2010 | 0.42x | HK$428.16 Million | HK$177.99 Million | ▲ +9.4% |
| 2009 | 0.38x | HK$270.85 Million | HK$102.94 Million | ▲ +10.3% |
| 2008 | 0.34x | HK$246.58 Million | HK$84.98 Million | ▼ -57.7% |
| 2007 | 0.81x | HK$87.70 Million | HK$71.41 Million | ▲ +25.2% |
| 2006 | 0.65x | HK$181.73 Million | HK$118.22 Million | ▲ +90.5% |
| 2005 | 0.34x | HK$148.28 Million | HK$50.62 Million | ▲ +213.6% |
| 2004 | 0.11x | HK$130.30 Million | HK$14.18 Million | ▼ -82.1% |
| 2003 | 0.61x | HK$81.22 Million | HK$49.36 Million | ▼ -35.0% |
| 2002 | 0.94x | HK$28.76 Million | HK$26.90 Million | ▲ +85.3% |
| 2001 | 0.50x | HK$71.16 Million | HK$35.91 Million | ▼ -79.5% |
| 2000 | 2.47x | HK$8.52 Million | HK$21.01 Million | ▲ +104.6% |
| 1999 | 1.21x | HK$22.84 Million | HK$27.54 Million | ▼ -39.5% |
| 1998 | 1.99x | HK$5.21 Million | HK$10.38 Million | — |